NCT00353028 Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents Status COMPLETED Phase PHASE4
NCT00351910 Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00351169 Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00335205 A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. Status UNKNOWN Phase PHASE4
NCT00326144 Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders Status COMPLETED Phase PHASE3
NCT00326105 Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders Status COMPLETED Phase PHASE3
NCT00321490 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00321152 A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE4
NCT00320268 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00305045 Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic Stimulation Status COMPLETED Phase NA
NCT00290914 Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT00289523 EEG Biomarkers for Predicting Response to Antidepressant Therapy Status COMPLETED Phase N/A